Search Results

Bioymifi 5mg 5mg  | Purity Not Available

Adooq Bioscience

Bioymifi is a potent and selective small molecule agonist of DR5 that directly targets DR5, specifically binds the ECD of DR5 (Kd ~1.2 ??M), and induces the formation of DR5 aggregates and DR5 activation.

More Information Supplier Page

Bioymifi 2mg 2mg  | Purity Not Available

Adooq Bioscience

Bioymifi is a potent and selective small molecule agonist of DR5 that directly targets DR5, specifically binds the ECD of DR5 (Kd ~1.2 ??M), and induces the formation of DR5 aggregates and DR5 activation.

More Information Supplier Page

Bioymifi 10mg 10mg  | Purity Not Available

Adooq Bioscience

Bioymifi is a potent and selective small molecule agonist of DR5 that directly targets DR5, specifically binds the ECD of DR5 (Kd ~1.2 ??M), and induces the formation of DR5 aggregates and DR5 activation.

More Information Supplier Page

BAM 7 50mg 50mg  | Purity Not Available

Adooq Bioscience

BAM 7 binds the BAX trigger site with an EC50 ~ 3.3 ??M as measured in a competitive FP assay using FITC-BIM SAHB and BAX.

More Information Supplier Page

BAM 7 5mg 5mg  | Purity Not Available

Adooq Bioscience

BAM 7 binds the BAX trigger site with an EC50 ~ 3.3 ??M as measured in a competitive FP assay using FITC-BIM SAHB and BAX.

More Information Supplier Page

BAM 7 25mg 25mg  | Purity Not Available

Adooq Bioscience

BAM 7 binds the BAX trigger site with an EC50 ~ 3.3 ??M as measured in a competitive FP assay using FITC-BIM SAHB and BAX.

More Information Supplier Page

BAM 7 10mg 10mg  | Purity Not Available

Adooq Bioscience

BAM 7 binds the BAX trigger site with an EC50 ~ 3.3 ??M as measured in a competitive FP assay using FITC-BIM SAHB and BAX.

More Information Supplier Page

Lupulone 10mg 10mg  | Purity Not Available

Adooq Bioscience

Lupulone, a hop bitter acid, activates different death pathways involving apoptotic TRAIL-receptors, in human colon tumor cells and in their derived metastatic cells.

More Information Supplier Page